Kinome-wide CRISPR-Cas9 knockout screens revealed PLK1 as a therapeutic target for osteosarcoma.
Wang R, Wang D, Bai X, Guo J, Xia S, Cheng Y, Gu Y, Wang Q, Nie J, Chen D, Liu W, Liang J.
Wang R, et al. Among authors: wang d, wang q.
Cell Death Discov. 2023 Jul 7;9(1):231. doi: 10.1038/s41420-023-01526-7.
Cell Death Discov. 2023.
PMID: 37419907
Free PMC article.